These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 4040366)
1. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines. Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366 [TBL] [Abstract][Full Text] [Related]
2. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids. Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661 [TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl. Yagi MJ; Bekesi JG Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339 [TBL] [Abstract][Full Text] [Related]
4. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity. Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia. Yagi MJ; Bekesi JG Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770 [TBL] [Abstract][Full Text] [Related]
6. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay. Yagi MJ; Zanjani M; Holland JF; Bekesi JG Cancer Chemother Pharmacol; 1984; 12(2):77-82. PubMed ID: 6697428 [TBL] [Abstract][Full Text] [Related]
7. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent. Yagi MJ; Maldarelli F; Chin SE; Holland JF; Bekesi JG J Natl Cancer Inst; 1986 Mar; 76(3):493-501. PubMed ID: 3005743 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcoma. Houghton PJ; Tharp R; Houghton JA; Holland JF; Bekesi JG Cancer Chemother Pharmacol; 1988; 22(3):201-4. PubMed ID: 3409455 [TBL] [Abstract][Full Text] [Related]
9. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo. Harrison SD; Brockman RW; Trader MW; Laster WR; Griswold DP Invest New Drugs; 1987 Dec; 5(4):345-51. PubMed ID: 3436739 [TBL] [Abstract][Full Text] [Related]
10. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926 [TBL] [Abstract][Full Text] [Related]
11. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide. Roboz J; Jiang J; Holland JF; Bekesi JG Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441 [TBL] [Abstract][Full Text] [Related]
12. Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies. Geroni C; Pesenti E; Tagliabue G; Ballinari D; Mongelli N; Broggini M; Erba E; D'Incalci M; Spreafico F; Grandi M Int J Cancer; 1993 Jan; 53(2):308-14. PubMed ID: 8425770 [TBL] [Abstract][Full Text] [Related]
13. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard. Schmid FA; Otter GM; Stock CC Cancer Res; 1980 Mar; 40(3):830-3. PubMed ID: 7471099 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin. Bigioni M; Salvatore C; Palma C; Manzini S; Animati F; Lombardi P; Pratesi G; Supino R; Zunino F Anticancer Drugs; 1997 Oct; 8(9):845-52. PubMed ID: 9402311 [TBL] [Abstract][Full Text] [Related]
15. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo. Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP Cancer Chemother Pharmacol; 1990; 25(6):425-9. PubMed ID: 2311170 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice. Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803 [TBL] [Abstract][Full Text] [Related]
17. Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. Yagi MJ; Scanlon KJ; Chin SE; Bekesi JG Chemotherapy; 1988; 34(1):61-70. PubMed ID: 2832130 [TBL] [Abstract][Full Text] [Related]
18. Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A. Pezzoni G; Grandi M; Biasoli G; Capolongo L; Ballinari D; Giuliani FC; Barbieri B; Pastori A; Pesenti E; Mongelli N Br J Cancer; 1991 Dec; 64(6):1047-50. PubMed ID: 1764367 [TBL] [Abstract][Full Text] [Related]
19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Kramer RA; Greene K; Ahmad S; Vistica DT Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359 [TBL] [Abstract][Full Text] [Related]
20. Immunopharmacological studies of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative. Allegrucci M; Ballerini P; Romani L; Frati L Immunopharmacol Immunotoxicol; 1987; 9(1):71-86. PubMed ID: 3450712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]